News
News

The latest updates from AFAR.

AFAR Welcomes New Board Member Nathaniel David, Ph.D.

Feb 16
2018

AFAR Welcomes New Board Member Nathaniel David, Ph.D. View MoreBACK

Nathaniel “Ned” David, Ph.D., a biochemist and biotech entrepreneur who co-founded UNITY Biotechnology and four other visionary biotech companies, has joined the AFAR’s Board of Directors.

David co-founded UNITY in 2011 along with three of the leading researchers in the field of cellular senescence, including AFAR grantee Judith Campisi, Ph.D.

David shares that he is honored to serve on AFAR’s Board of Directors, having seen firsthand the impact that the organization’s support for biomedical research makes: “Were it not for AFAR and its far-sighted vision going back three decades, UNITY—in its current form—wouldn’t exist.”

Before UNITY, David co-founded Syrrx (acquired by Takeda), Achaogen (AKAO), Kythera Biopharmaceuticals (KYTH, acquired by Allergan), and Sapphire Energy. Together, they raised over $1.5 billion in financing and today employ more than 400 scientists, engineers, and business people. David holds pending and issued patents in fields such as nanovolume crystallography, antibiotic resistance, aesthetic medicine, and cellular senescence. He has served on the board of directors of Kythera Biopharmaceuticals, Sapphire Energy, and the Buck Institute for Research on Aging and is a member of the board of trustees of the University of California Foundation. He holds a Ph.D. from the University of California, Berkeley in Molecular and Cellular Biology and an A.B. in Biology from Harvard University.


AFAR previously honored David with its 2017 Honorary Leadership Award for his commitment to innovations to extend healthspan. At the award ceremony, Dr. David spoke passionately about AFAR’s contribution to the field. Watch Dr. David’s acceptance speech here and hear more of his insights in a panel on biotech and aging here.

Learn more about Nathaniel David in his press release here.

For a complete list of AFAR's esteemed Board of Directors, please click here.





View MoreBACK TO TOP